United States (US) Oncology Molecular Diagnostic Market (2025-2031) | Trends, Value, Size & Revenue, Growth, Segmentation, Analysis, Forecast, Competitive Landscape, Share, Companies, Industry, Outlook

Name: United States (US) Oncology Molecular Diagnostic Market (2025-2031) | Trends & Value
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Type (Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, Others), By Product (Instruments, Reagents, Others), By Test Location (Clinics, Other Establishments, Point of Care), By Technology (PCR, Multiplex, Others, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology (INAAT), Chips and Microarrays, Mass Spectrometry, Others), By End User (Hospitals, Diagnostic Centers) And Competitive Landscape

Product Code: ETC9972037	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Dhaval Chaurasia	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Oncology Molecular Diagnostic Market Outlook
Market Size of United States (US) Oncology Molecular Diagnostic Market, 2024
Forecast of United States (US) Oncology Molecular Diagnostic Market, 2031
Historical Data and Forecast of United States (US) Oncology Molecular Diagnostic Revenues & Volume for the Period 2021- 2031
United States (US) Oncology Molecular Diagnostic Market Trend Evolution
United States (US) Oncology Molecular Diagnostic Market Drivers and Challenges
United States (US) Oncology Molecular Diagnostic Price Trends
United States (US) Oncology Molecular Diagnostic Porter's Five Forces
United States (US) Oncology Molecular Diagnostic Industry Life Cycle
Historical Data and Forecast of United States (US) Oncology Molecular Diagnostic Market Revenues & Volume By Type for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Molecular Diagnostic Market Revenues & Volume By Breast Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Molecular Diagnostic Market Revenues & Volume By Prostate Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Molecular Diagnostic Market Revenues & Volume By Colorectal Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Molecular Diagnostic Market Revenues & Volume By Cervical Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Molecular Diagnostic Market Revenues & Volume By Liver Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Molecular Diagnostic Market Revenues & Volume By Lung Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Molecular Diagnostic Market Revenues & Volume By Blood Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) Breast Cancer Oncology Molecular Diagnostic Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Molecular Diagnostic Market Revenues & Volume By Product for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Molecular Diagnostic Market Revenues & Volume By Instruments for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Molecular Diagnostic Market Revenues & Volume By Reagents for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Molecular Diagnostic Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Molecular Diagnostic Market Revenues & Volume By Test Location for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Molecular Diagnostic Market Revenues & Volume By Clinics for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Molecular Diagnostic Market Revenues & Volume By Other Establishments for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Molecular Diagnostic Market Revenues & Volume By Point of Care for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Molecular Diagnostic Market Revenues & Volume By Technology for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Molecular Diagnostic Market Revenues & Volume By PCR for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Molecular Diagnostic Market Revenues & Volume By Multiplex for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Molecular Diagnostic Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Molecular Diagnostic Market Revenues & Volume By In Situ Hybridization for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Molecular Diagnostic Market Revenues & Volume By Isothermal Nucleic Acid Amplification Technology (INAAT) for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Molecular Diagnostic Market Revenues & Volume By Chips and Microarrays for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Molecular Diagnostic Market Revenues & Volume By Mass Spectrometry for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Molecular Diagnostic Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Molecular Diagnostic Market Revenues & Volume By End User for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Molecular Diagnostic Market Revenues & Volume By Hospitals for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Molecular Diagnostic Market Revenues & Volume By Diagnostic Centers for the Period 2021- 2031
United States (US) Oncology Molecular Diagnostic Import Export Trade Statistics
Market Opportunity Assessment By Type
Market Opportunity Assessment By Product
Market Opportunity Assessment By Test Location
Market Opportunity Assessment By Technology
Market Opportunity Assessment By End User
United States (US) Oncology Molecular Diagnostic Top Companies Market Share
United States (US) Oncology Molecular Diagnostic Competitive Benchmarking By Technical and Operational Parameters
United States (US) Oncology Molecular Diagnostic Company Profiles
United States (US) Oncology Molecular Diagnostic Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Oncology Molecular Diagnostic Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Oncology Molecular Diagnostic Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Oncology Molecular Diagnostic Market - Industry Life Cycle

3.4 United States (US) Oncology Molecular Diagnostic Market - Porter's Five Forces

3.5 United States (US) Oncology Molecular Diagnostic Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 United States (US) Oncology Molecular Diagnostic Market Revenues & Volume Share, By Product, 2021 & 2031F

3.7 United States (US) Oncology Molecular Diagnostic Market Revenues & Volume Share, By Test Location, 2021 & 2031F

3.8 United States (US) Oncology Molecular Diagnostic Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.9 United States (US) Oncology Molecular Diagnostic Market Revenues & Volume Share, By End User, 2021 & 2031F

4 United States (US) Oncology Molecular Diagnostic Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing incidence of cancer cases in the United States

4.2.2 Growing demand for personalized medicine and targeted therapies in oncology

4.2.3 Advancements in molecular diagnostic technologies improving accuracy and efficiency

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for approval and commercialization of molecular diagnostic tests

4.3.2 High costs associated with oncology molecular diagnostics testing

4.3.3 Limited reimbursement policies for molecular diagnostic tests

5 United States (US) Oncology Molecular Diagnostic Market Trends

6 United States (US) Oncology Molecular Diagnostic Market, By Types

6.1 United States (US) Oncology Molecular Diagnostic Market, By Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Oncology Molecular Diagnostic Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 United States (US) Oncology Molecular Diagnostic Market Revenues & Volume, By Breast Cancer, 2021- 2031F

6.1.4 United States (US) Oncology Molecular Diagnostic Market Revenues & Volume, By Prostate Cancer, 2021- 2031F

6.1.5 United States (US) Oncology Molecular Diagnostic Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F

6.1.6 United States (US) Oncology Molecular Diagnostic Market Revenues & Volume, By Cervical Cancer, 2021- 2031F

6.1.7 United States (US) Oncology Molecular Diagnostic Market Revenues & Volume, By Liver Cancer, 2021- 2031F

6.1.8 United States (US) Oncology Molecular Diagnostic Market Revenues & Volume, By Lung Cancer, 2021- 2031F

6.1.9 United States (US) Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F

6.1.10 United States (US) Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F

6.2 United States (US) Oncology Molecular Diagnostic Market, By Product

6.2.1 Overview and Analysis

6.2.2 United States (US) Oncology Molecular Diagnostic Market Revenues & Volume, By Instruments, 2021- 2031F

6.2.3 United States (US) Oncology Molecular Diagnostic Market Revenues & Volume, By Reagents, 2021- 2031F

6.2.4 United States (US) Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F

6.3 United States (US) Oncology Molecular Diagnostic Market, By Test Location

6.3.1 Overview and Analysis

6.3.2 United States (US) Oncology Molecular Diagnostic Market Revenues & Volume, By Clinics, 2021- 2031F

6.3.3 United States (US) Oncology Molecular Diagnostic Market Revenues & Volume, By Other Establishments, 2021- 2031F

6.3.4 United States (US) Oncology Molecular Diagnostic Market Revenues & Volume, By Point of Care, 2021- 2031F

6.4 United States (US) Oncology Molecular Diagnostic Market, By Technology

6.4.1 Overview and Analysis

6.4.2 United States (US) Oncology Molecular Diagnostic Market Revenues & Volume, By PCR, 2021- 2031F

6.4.3 United States (US) Oncology Molecular Diagnostic Market Revenues & Volume, By Multiplex, 2021- 2031F

6.4.4 United States (US) Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F

6.4.5 United States (US) Oncology Molecular Diagnostic Market Revenues & Volume, By In Situ Hybridization, 2021- 2031F

6.4.6 United States (US) Oncology Molecular Diagnostic Market Revenues & Volume, By Isothermal Nucleic Acid Amplification Technology (INAAT), 2021- 2031F

6.4.7 United States (US) Oncology Molecular Diagnostic Market Revenues & Volume, By Chips and Microarrays, 2021- 2031F

6.4.8 United States (US) Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F

6.4.9 United States (US) Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F

6.5 United States (US) Oncology Molecular Diagnostic Market, By End User

6.5.1 Overview and Analysis

6.5.2 United States (US) Oncology Molecular Diagnostic Market Revenues & Volume, By Hospitals, 2021- 2031F

6.5.3 United States (US) Oncology Molecular Diagnostic Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F

7 United States (US) Oncology Molecular Diagnostic Market Import-Export Trade Statistics

7.1 United States (US) Oncology Molecular Diagnostic Market Export to Major Countries

7.2 United States (US) Oncology Molecular Diagnostic Market Imports from Major Countries

8 United States (US) Oncology Molecular Diagnostic Market Key Performance Indicators

8.1 Adoption rate of new molecular diagnostic technologies in oncology

8.2 Rate of integration of molecular diagnostic results into treatment decisions

8.3 Number of clinical trials incorporating molecular diagnostics for oncology treatments

9 United States (US) Oncology Molecular Diagnostic Market - Opportunity Assessment

9.1 United States (US) Oncology Molecular Diagnostic Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 United States (US) Oncology Molecular Diagnostic Market Opportunity Assessment, By Product, 2021 & 2031F

9.3 United States (US) Oncology Molecular Diagnostic Market Opportunity Assessment, By Test Location, 2021 & 2031F

9.4 United States (US) Oncology Molecular Diagnostic Market Opportunity Assessment, By Technology, 2021 & 2031F

9.5 United States (US) Oncology Molecular Diagnostic Market Opportunity Assessment, By End User, 2021 & 2031F

10 United States (US) Oncology Molecular Diagnostic Market - Competitive Landscape

10.1 United States (US) Oncology Molecular Diagnostic Market Revenue Share, By Companies, 2024

10.2 United States (US) Oncology Molecular Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Oncology Molecular Diagnostic Market

Eritrea Oncology Molecular Diagnostic Market

Estonia Oncology Molecular Diagnostic Market

Ethiopia Oncology Molecular Diagnostic Market

Fiji Oncology Molecular Diagnostic Market

Finland Oncology Molecular Diagnostic Market

Global Oncology Molecular Diagnostic Market

Middle East Oncology Molecular Diagnostic Market

North America Oncology Molecular Diagnostic Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here